Stay updated on ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new Study Status section was added to the record history on 2026-09-22, and a new version entry dated 2026-09-21 (version 14) was created to reflect updated status. Additionally, the prior entry dated 2026-04-13 was removed from the history.
    Difference
    0.4%
    Check dated 2026-09-22T23:10:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The record history now includes a new revision labeled v3.7.0. The previous revision v3.6.6 has been removed, indicating a version update to the page rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-15T21:47:44.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A new revision v3.6.6 was added to the study history, indicating an administrative update to the record; the update does not modify substantive details of the trial.
    Difference
    0.1%
    Check dated 2026-09-01T18:30:36.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    A new revision entry labeled 'Revision: v3.6.5' was added to the study record history, representing an update to the page content. The previous revision 'Revision: v3.6.4' was removed from the history.
    Difference
    0.1%
    Check dated 2026-08-11T18:22:21.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 was added to the study record history, replacing the previous revision v3.6.3, indicating an administrative update to the record.
    Difference
    0.1%
    Check dated 2026-07-21T13:23:05.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page's revision history now shows a new entry for revision v3.6.3, and the previous revision v3.6.2 is removed, updating the documented version history to reflect the latest release.
    Difference
    0.1%
    Check dated 2026-07-07T02:43:05.000Z thumbnail image

Stay in the know with updates to ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.